U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596342) titled 'Electrophysiological Analysis of Gamma-Hydroxybutyrate-induced Sleep in Intensive Care Patients' on April 30.
Brief Summary: In intensive care, sleep disturbances are extremely common and represent a major source of discomfort for patients. Restorative sleep is very limited. Beyond being the primary source of discomfort reported by patients, these sleep disturbances are associated with difficulties in weaning from mechanical ventilation, an increased risk of delirium, and potentially higher mortality. Traditional treatments artificially increase the total duration of sleep but lead to disrupted sleep architecture.
Gamma-hydroxybutyr...